How do the GLP-1 medications Semaglutide and Tirzepatide work for weight loss
The study, which analyzed six years of medical data, focused on more than 16,000 patients in the Boston area, revealing that 37 individuals across both diabetes and weight loss groups developed NAION after starting semaglutide
Our primary focus is to ensure your safety and the effectiveness of the treatment throughout your weight loss journey
His doctors told him he had developed non-arteritic anterior ischemic optic neuropathy (NAION), which is vision loss that is sudden, painless, and irreversible in most cases
For patients seeking maximal weight loss results, Zepbound (tirzepatide), a dual GIP/GLP-1 agonist, targets two hormones for enhanced effects
Being part of a program or having access to professional advice can significantly increase your chances of success